Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cetuximab, a chimeric mouse-human IgG1 monoclonal antibody against the epidermal growth factor receptor, is approved for use in colorectal cancer and squamous-cell carcinoma of the head and neck. A high prevalence of hypersensitivity reactions to cetuximab has been reported in some areas of the United States. METHODS: We analyzed serum samples from four groups of subjects for IgE antibodies against cetuximab: pretreatment samples from 76 case subjects who had been treated with cetuximab at multiple centers, predominantly in Tennessee, Arkansas, and North Carolina; samples from 72 control subjects in Tennessee; samples from 49 control subjects with cancer in northern California; and samples from 341 female control subjects in Boston. RESULTS: Among 76 cetuximab-treated subjects, 25 had a hypersensitivity reaction to the drug. IgE antibodies against cetuximab were found in pretreatment samples from 17 of these subjects; only 1 of 51 subjects who did not have a hypersensitivity reaction had such antibodies (P<0.001). IgE antibodies against cetuximab were found in 15 of 72 samples (20.8%) from control subjects in Tennessee, in 3 of 49 samples (6.1%) from northern California, and in 2 of 341 samples (0.6%) from Boston. The IgE antibodies were shown to be specific for an oligosaccharide, galactose-alpha-1,3-galactose, which is present on the Fab portion of the cetuximab heavy chain. CONCLUSIONS: In most subjects who had a hypersensitivity reaction to cetuximab, IgE antibodies against cetuximab were present in serum before therapy. The antibodies were specific for galactose-alpha-1,3-galactose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Humans also lack the ability to produce the Galα1–3Galβ1–4GlcNAc–R epitope, which is common in murine cells, and this has been shown to induce anaphylaxis [8,33].”
From Glycoengineering Chinese hamster ovary cells: a short history (2021) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Murine cells can also produce α-gal and Neu5Gc at considerably higher levels than hamster cells, increasing the risks of immunogenicity (Tangvoranuntakul et al., 2003;Chung et al., 2008;Macher and Galili, 2008;Padler-Karavani et al., 2008;Ghaderi et al., 2012).”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Chung et al., 2008
Experimental — accuracy not yet measuredIn the citing paper
“However, anti-α-Gal IgE antibodies can cause allergic reactions, such as anaphylaxis, against cetuximab, a therapeutic monoclonal antibody targeting epidermal growth factor receptor (EGFR)”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Chung et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
Edwards, J. C. W., Szczepański, L., Szechiński, J., Filipowicz-Sosnowska, A., Emery, P., Close, D. R., Stevens, R. M., & Shaw, T. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032534 · Cited by 2,623
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
Chung, K. Y., Shia, J., Kemeny, N. E., Shah, M., Schwartz, G. K., Tse, A., Hamilton, A., Pan, D., Schrag, D., Schwartz, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.037 · Cited by 1,081
(1945) · Harvard University Press eBooks · doi:10.4159/harvard.9780674184220 · Cited by 1,078
The diagnosis and management of anaphylaxis: An updated practice parameter
LIEBERMAN, P., KEMP, S., OPPENHEIMER, J., LANG, D., BERNSTEIN, I., NICKLAS, R., ANDERSON, J., BERNSTEIN, D., BERNSTEIN, J., & FINK, J. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.01.010 · Cited by 667
Symposium on the Definition and Management of Anaphylaxis: Summary report
Sampson, H. A., Muñoz-Furlong, A., Bock, S. A., Schmitt, C., Bass, R., Chowdhury, B. A., Decker, W. W., Furlong, T. J., Galli, S. J., Golden, D. B., et al. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.01.009 · Cited by 641
The incidence and management of infusion reactions to infliximab: a large center experience
Cheifetz, A. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00231-4 · Cited by 491
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation
Holgate, S., Casale, T., Wenzel, S., Bousquet, J., Deniz, Y., & Reisner, C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.053 · Cited by 466
Research works printed but not linked: 1
- Carolina; association with atopic history. J Clin Oncol 2007;25:3644-8.
Cited by
Items 501–600 of 1,002
Orthogonal Technologies for NISTmAb N-Glycan Structure Elucidation and Quantitation
Prien, J. M., Stöckmann, H., Albrecht, S., Millán‐Martín, S., Varatta, M., Furtado, M., Hosselet, S., Wang, M., Formolo, T., Rudd, P. M., et al. (2015) · ACS symposium series · doi:10.1021/bk-2015-1201.ch004 · Cited by 36
Nadeem, T., Khan, M. A., Ijaz, B., Ahmed, N., Rahman, Z. U., Latif, M. S., Ali, Q., & Rana, M. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0032 · Cited by 35
Hypersensitivity Reactions to Biologicals: from Bench to Bedside
Akarsu, A., Soyer, Ö., & Şekerel, B. E. (2020) · Current Treatment Options in Allergy · doi:10.1007/s40521-020-00242-2 · Cited by 33
Peruško, M., Apostolović, D., Kiewiet, M. B. G., Grundström, J., Hamsten, C., Starkhammar, M., Veličković, T. Ć., & van Hage, M. (2021) · Allergy · doi:10.1111/all.14889 · Cited by 34
Prevention of Drug Hypersensitivity Reactions: Prescreening and Premedication
Thong, B. Y., Vultaggio, A., Rerkpattanapipat, T., & Schrijvers, R. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.04.006 · Cited by 35
Seppälä, U., Selby, D., Monsalve, R. I., King, T. P., Ebner, C., Roepstorff, P., & Bohle, B. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.03.005 · Cited by 33
Effectiveness of COVID‑19 vaccines and their challenges (Review)
Marfè, G., Perna, S., & Shukla, A. K. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10843 · Cited by 37
Engineering therapeutic monoclonal antibodies
Stone, C. A., Spiller, B. W., & Smith, S. A. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.11.018 · Cited by 34
Dienstmann, R., & Felip, E. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.595709 · Cited by 32
Plum, M., Michel, Y., Wallach, K., Raiber, T., Blank, S., Bantleon, F. I., Diethers, A., Greunke, K., Braren, I., Hackl, T., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.291823 · Cited by 35
Liu, H., Nowak, C., Andrien, B. A., Shao, M., Ponniah, G., & Neill, A. (2017) · Biotechnology Progress · doi:10.1002/btpr.2498 · Cited by 35
Zhang, P., Chan, K. F., Haryadi, R., Bardor, M., & Song, Z. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_163 · Cited by 33
IgE‐based immunotherapy of cancer: challenges and chances
Singer, J., & Jensen‐Jarolim, E. (2013) · Allergy · doi:10.1111/all.12276 · Cited by 35
Desai, D., Goldbach‐Mansky, R. T., Milner, J. D., Rabin, R. L., Hull, K. M., Pucino, F., & Colburn, N. T. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l573 · Cited by 31
Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS
Wooding, K. M., Peng, W., & Mechref, Y. S. (2016) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201017666160401145012 · Cited by 32
Biologic response modifiers: Indications, implications, and insights
Davis, B. P., & Ballas, Z. K. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.02.013 · Cited by 33
Diagnosis of red meat allergy with antigen-specific IgE tests in serum
Brestoff, J. R., Zaydman, M. A., Scott, M. G., & Gronowski, A. M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.032 · Cited by 32
Desensitization for Allergic Reactions to Chemotherapy
Hong, D. I. (2019) · Yonsei Medical Journal · doi:10.3349/ymj.2019.60.2.119 · Cited by 33
The 100 top-cited studies in cancer immunotherapy
Zhang, Y., Quan, L., & Du, L. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1623234 · Cited by 32
The role of glycosylation in clinical allergy and immunology
Hale, R. C., Morais, D., Chou, J. S., & Stowell, S. R. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.09.003 · Cited by 31
Hansen, N. L., Chandiramani, D. V., Morse, M. A., Wei, D., Hedrick, N. E., & Hansen, R. A. (2010) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155209360853 · Cited by 31
Self-citationEngineering therapeutic antibodies for patient safety: tackling the immunogenicity problem
Ulitzka, M., Carrara, S. C., Grzeschik, J., Kornmann, H., Hock, B. M., & Kolmar, H. (2020) · Protein Engineering Design and Selection · doi:10.1093/protein/gzaa025 · Cited by 32
Li, S., Gray, B. P., McGuire, M. J., & Brown, K. C. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.07.046 · Cited by 31
Lai, J. D., Swystun, L. L., Cartier, D., Nesbitt, K., Zhang, C., Hough, C. A., Dennis, J. W., & Lillicrap, D. (2018) · Haematologica · doi:10.3324/haematol.2018.188219 · Cited by 30
Development of hypoallergenic galacto-oligosaccharides on the basis of allergen analysis
Kaneko, K., Watanabe, Y., Kimura, K., Matsumoto, K., Mizobuchi, T., & Onoue, M. (2014) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.877819 · Cited by 30
Barbosa, M. D. F. S., Kumar, S., Loughrey, H. C., & Singh, S. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.003 · Cited by 34
Yang, C., Xu, C., Wang, X., & Hu, X. (2012) · The Analyst · doi:10.1039/c2an15894a · Cited by 30
Murine Plasma N-Glycosylation Traits Associated with Sex and Strain
Reiding, K. R., Ederveen, A. L. H., Rombouts, Y., & Wuhrer, M. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00071 · Cited by 34
Nencini, F., Vultaggio, A., Pratesi, S., Cammelli, D., Milla, M., FIORI, G., Bagnoli, S., Prignano, F., Romagnani, S., Maggi, E., et al. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.04.007 · Cited by 30
N-Linked Glycan Structures of the Human Fcγ Receptors Produced in NS0 Cells
Cosgrave, E. F. J., Struwe, W. B., Hayes, J. M., Harvey, D. J., Wormald, M. R., & Rudd, P. M. (2013) · Journal of Proteome Research · doi:10.1021/pr400344h · Cited by 31
In vitro assays supporting the safety assessment of immunomodulatory monoclonal antibodies
Brennan, F. R., & Kießling, A. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.02.025 · Cited by 29
Monoclonal Antibodies Hypersensitivity
dos Santos, R. B., & Galvão, V. R. (2017) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2017.07.003 · Cited by 30
Stable Protein Sialylation in Physcomitrella
Bohlender, L. L., Parsons, J., Hoernstein, S. N. W., Rempfer, C., Ruiz-Molina, N., Lorenz, T., Rodríguez-Jahnke, F., Figl, R., Fode, B., Altmann, F., et al. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.610032 · Cited by 33
Evaluation of IgE Antibodies to Omalizumab (Xolair®) and Their Potential Correlation to Anaphylaxis
Baker, D. L., Nakamura, G. R., Lowman, H. B., & Fischer, S. K. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9821-x · Cited by 29
Nanomedicine in Chemoradiation
Miller, S., & Wang, A. Z. (2013) · Therapeutic Delivery · doi:10.4155/tde.12.147 · Cited by 30
Song, X., Long, S. R., Barber, B., Kassed, C. A., Healey, M., Jones, C., & Zhao, Z. (2012) · Current Clinical Pharmacology · doi:10.2174/157488412799218806 · Cited by 28
A bite so sweet: the glycobiology interface of tick-host-pathogen interactions
Věchtová, P., Sterbova, J., Štěrba, J., Vancová, M., Rego, R. O. M., Selinger, M., Strnad, M., Golovchenko, M., Rudenko, N., & Grubhoffer, L. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-3062-7 · Cited by 33
Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors
Li, S., McCraw, A. J., Gardner, R. A., Spencer, D. I. R., Karagiannis, S. N., & Wagner, G. K. (2021) · Antibodies · doi:10.3390/antib10040044 · Cited by 31
Langerak, A. D., River, G. L., Mitchell, E. P., Cheema, P. S., & Shing, M. (2009) · Clinical Colorectal Cancer · doi:10.3816/ccc.2009.n.008 · Cited by 28
Carmine dye and cochineal extract: hidden allergens no more
Greenhawt, M., & Baldwin, J. L. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60146-9 · Cited by 28
Saeui, C. T., Urias, E., Liu, L., Mathew, M. P., & Yarema, K. J. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9583-9 · Cited by 28
Cetuximab hypersensitivity infusion reactions: Incidence and risk factors
Hopps, S., Medina, P. J., Pant, S., Webb, R. D., Moorman, M., & Borders, E. B. (2012) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155212462440 · Cited by 28
Complex N-Glycans Are Important for Normal Fruit Ripening and Seed Development in Tomato
Kaulfürst-Soboll, H., Mertens-Beer, M., Brehler, R., Albert, M., & von Schaewen, A. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.635962 · Cited by 28
Antibody engineering to develop new antirheumatic therapies
Isaacs, J. D. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2594 · Cited by 32
Targeted genetic and viral therapy for advanced head and neck cancers
Huang, P., Chang, J.-F., Kirn, D. H., & Liu, T. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.03.008 · Cited by 28
Comparative Immunogenicity Assessment: A Critical Consideration for Biosimilar Development
Liu, P. M., Zou, L., Sadhu, C., Shen, W. D., & Nock, S. (2015) · Bioanalysis · doi:10.4155/bio.14.311 · Cited by 27
Jedrzejewski, P., del Val, I. J., Polizzi, K. M., & Kontoravdi, C. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.4 · Cited by 30
Berre, L. L., Rousse, J., Gourraud, P., Imbert‐Marcille, B., Salama, A., Evanno, G., Sémana, G., Nicot, A. B., Dugast, E., Guérif, P., et al. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.05.006 · Cited by 28
Medical algorithm: Diagnosis and treatment of drug hypersensitivity reactions to biologicals
Yang, B. C., & Castells, M. (2020) · Allergy · doi:10.1111/all.14432 · Cited by 29
Alpha-gal syndrome: A review for the dermatologist
Reddy, S. M., Yi, L. G., Shields, B. E., Platts‐Mills, T. A. E., Wilson, J., & Flowers, R. H. (2023) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2023.04.054 · Cited by 30
Self-citationHelminth-Induced IgE and Protection Against Allergic Disorders
Hamid, F., Amoah, A. S., van Ree, R., & Yazdanbakhsh, M. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-13725-4_5 · Cited by 28
Wiegandt, A., & Meyer, B. (2014) · Analytical Chemistry · doi:10.1021/ac404043g · Cited by 28
Strategies for Engineering Protein N-Glycosylation Pathways in Mammalian Cells
Wang, Q., Stuczynski, M. C., Gao, Y., & Betenbaugh, M. J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2760-9_20 · Cited by 31
Commins, S. P. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.12.003 · Cited by 33
Gülşen, A., Wedi, B., & Jappe, U. (2020) · Allergo Journal International · doi:10.1007/s40629-020-00127-5 · Cited by 27
Freeman, D. J., Bush, T. L., Ogbagabriel, S., Belmontes, B., Juan, T., Plewa, C. A., Van, G. Y., Johnson, C., & Radinsky, R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0978 · Cited by 28
Clinical Presentation and Outcomes of Alpha-Gal Syndrome
Lesmana, E., Rao, S., Keehn, A., Edwinson, A. L., Makol, A., & Grover, M. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.06.044 · Cited by 28
Walker, M., Makropoulos, D., Achuthanandam, R., Arsdell, S. V., & Bugelski, P. J. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.06.001 · Cited by 27
Rusthoven, K. E., Feigenberg, S. J., Raben, D., Kane, M. A., Song, J. I., Nicolaou, N., Mehra, R., Burtness, B. A., Ridge, J. A., Swing, R., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.003 · Cited by 26
The safety of monoclonal antibodies for treatment of colorectal cancer
Berger, M. D., & Lenz, H. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1167186 · Cited by 27
Schmidle, P., Mehlich, J., Brockow, K., Darsow, U. G., Biedermann, T., & Eberlein, B. (2021) · International Archives of Allergy and Immunology · doi:10.1159/000514263 · Cited by 26
The expanding spectrum of disease caused by the Lone Star Tick, Amblyomma americanum
Iván, N., Franco‐Paredes, C., & Henao‐Martínez, A. F. (2021) · Infezioni in Medicina · doi:10.53854/liim-2903-8 · Cited by 26
Perioperative implications of patients with alpha gal allergies
Nourian, M. M., Stone, C. A., Siegrist, K. K., & Riess, M. L. (2023) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2023.111056 · Cited by 26
Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
Thomas, B. J., Guldenpfennig, C., Guan, Y., Winkler, C., Beecher, M., Beedy, M., Berendzen, A. F., Ma, L., Daniëls, M. A., Burke, D. H., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102046 · Cited by 26
B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera
Homann, A., Röckendorf, N., Kromminga, A., Frey, A., & Jappe, U. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0706-7 · Cited by 28
Integrating anti-EGFR therapies in metastatic colorectal cancer.
Haraldsdóttir, S., & Bekaii‐Saab, T. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2013.028 · Cited by 28
Immunogenicity of panitumumab in combination chemotherapy clinical trials
Weeraratne, D. K., Chen, A., Pennucci, J. J., Wu, C., Zhang, K., Wright, J., Ruixo, J. J. P., Yang, B., Kaliyaperumal, A., Gupta, S., et al. (2011) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-11-17 · Cited by 28
Recombinant IgE antibody engineering to target EGFR
Spillner, E., Plum, M., Blank, S., Miehe, M., Singer, J., & Braren, I. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1287-4 · Cited by 27
Geisler, C., & Jarvis, D. L. (2012) · Metabolic Engineering · doi:10.1016/j.ymben.2012.08.005 · Cited by 26
The Expanding Role of Therapeutic Antibodies
Salemi, S., Marković, M., Martini, G., & D’Amelio, R. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2013.863304 · Cited by 28
High-Throughput Quantitative N-Glycan Analysis of Glycoproteins
Doherty, M., McManus, C. A., Duke, R. M., & Rudd, P. M. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-921-1_19 · Cited by 26
Decuyper, I. I., Ebo, D. G., Uyttebroek, A. P., Hagendorens, M. M., Faber, M. A., Bridts, C. H., Clerck, L. S. D., & Sabato, V. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.06.043 · Cited by 29
Saccomano, M., Dullin, C., Alves, F., & Napp, J. (2016) · International Journal of Cancer · doi:10.1002/ijc.30277 · Cited by 26
Li, X., Clements‐Egan, A., Amaravadi, L. S., Birchler, M., Gorovits, B., Liang, M., Myler, H. A., Purushothama, S., Manning, M. S., & Sung, C. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0153-x · Cited by 26
Flexible Synthetic Carbohydrate Receptors as Inhibitors of Viral Attachment
Bravo, M. F., Lema, M. A., Marianski, M., & Braunschweig, A. B. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00732 · Cited by 26
Safety Issues Specific to Clinical Development of Protein Therapeutics
Haller, C., Cosenza, M., & Jt, S. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.158 · Cited by 26
Monoclonal Antibodies as Therapeutics in Human Malignancies
Pandey, M., & Mahadevan, D. (2014) · Future Oncology · doi:10.2217/fon.13.197 · Cited by 29
Yu, C., Gao, K., Zhu, L., Wang, W., Wang, L., Zhang, F., Liu, C., Li, M., Wormald, M. R., Rudd, P. M., et al. (2016) · Scientific Reports · doi:10.1038/srep20029 · Cited by 25
Parasites and allergy: Observations from Africa
Mpairwe, H., & Amoah, A. S. (2018) · Parasite Immunology · doi:10.1111/pim.12589 · Cited by 27
What are clinically significant anti-drug antibodies and why is it important to identify them
Swanson, S. J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401178 · Cited by 25
Galili, U. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.746883 · Cited by 25
Zeunik, R., Ryuzoji, A. F., Peariso, A., Wang, X., Lannan, M. B., Spindler, L. J., Knierman, M. D., Copeland, V., Patel, C. N., & Wen, Y. (2022) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2022.05.005 · Cited by 27
Lee, Y.-J., Jung, E., Choi, J., Hwang, J.-S., Jeong, E.-J., Roh, Y., Ban, H. S., Kim, S., Kim, S., Kim, S., et al. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5461 · Cited by 26
Allergy in Cancer Care: Antineoplastic Therapy-Induced Hypersensitivity Reactions
Gălățeanu, B., Pușcașu, A., Tircol, S. A., Tănase, B. C., Hudiță, A., Negrei, C., Burcea-Dragomiroiu, G.-T.-A., Negreanu, L. M., Văcăroiu, I. A., & Ginghină, O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043886 · Cited by 25
Recent insights into the mechanisms of anaphylaxis
Stevens, W. W., Kraft, M., & Eisenbarth, S. C. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102288 · Cited by 28
Anticorps thérapeutiques et dérivés : une palette de structures pour une pléthore d’indications
Beck, A., Wagner‐Rousset, E., Wurch, T., & Corvaïa, N. (2009) · médecine/sciences · doi:10.1051/medsci/200925121024 · Cited by 28
Fischer, J., & Biedermann, T. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12821 · Cited by 26
Comprehensive N-Glycan Profiling of Avian Immunoglobulin Y
Gilgunn, S., Millán‐Martín, S., Wormald, M. R., Zapatero-Rodríguez, J., Conroy, P. J., O’Kennedy, R. J., Rudd, P. M., & Saldova, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159859 · Cited by 28
Chiang, A. W. T., Li, S., Spahn, P. N., Richelle, A., Kuo, C., Samoudi, M., & Lewis, N. E. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.08.008 · Cited by 27
Red meat desensitization in a child with delayed anaphylaxis due to alpha‐Gal allergy
Yucel, E., Sipahi Cimen, S., Varol, S., Suleyman, A., Ozdemir, C., & Tamay, Z. U. (2019) · Pediatric Allergy and Immunology · doi:10.1111/pai.13092 · Cited by 24
Current Development of Monoclonal Antibodies in Cancer Therapy
Parakh, S., King, D., Gan, H. K., & Scott, A. M. (2019) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-030-23765-3_1 · Cited by 28
Váradi, C., Jakes, C., & Bones, J. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.113035 · Cited by 27
The History of Carbohydrates in Type I Allergy
Hils, M., Wölbing, F., Hilger, C., Fischer, J., Hoffard, N., & Biedermann, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586924 · Cited by 26
Touma, W., Koro, S. S., Ley, J. C., Wildes, T. M., Michel, L. S., Tao, Y., & Adkins, D. R. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.06.017 · Cited by 25
Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer
Wen, F., & Li, Q. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i23.5332 · Cited by 26
Clinical potential of necitumumab in non-small cell lung carcinoma
Hirsch, F. R., & Genova, C. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s114039 · Cited by 24
Khuda, S. E., Nguyen, A. V., Sharma, G. M., Alam, M. S., Balan, K. V., & Williams, K. M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100576 · Cited by 25
Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
Chow, T. G., Franzblau, L. E., & Khan, D. A. (2022) · Current Allergy and Asthma Reports · doi:10.1007/s11882-022-01048-9 · Cited by 24
McGill, S., Commins, S. P., Peery, A. F., Galanko, J. A., Keku, T. O., Shaheen, N. J., Anderson, C., & Sandler, R. S. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002219 · Cited by 24
Biomanufacturing of glycosylated antibodies: Challenges, solutions, and future prospects
Dubey, K. K., Kumar, A., Baldia, A., Rajput, D., Kateriya, S., Singh, R., Nikita, N., Tandon, R., & Mishra, Y. K. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108267 · Cited by 25
Metadata
- Authors
- Chung, C. H., Mirakhur, B., Chan, E., Le, Q.-T., Berlin, J., Morse, M., Murphy, B. A., Satinover, S. M., Hosen, J., Mauro, D., Slebos, R. J., Zhou, Q., Gold, D., Hatley, T., Hicklin, D. J., & Platts-Mills, T. A. E.
- Affiliations
- Vanderbilt University (US)
- Bristol-Myers Squibb (United States) (US)
- Stanford University (US)
- Duke Medical Center (US)
- University of Virginia (US)
- Harvard University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-03-13
- Volume
- 358
- Issue
- 11
- Pages
- 1109-1117
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2361129
- OpenAlex
- W2140035322
- Cited by
- 1,521
- References
- 35
- Citations by year
- 2026: 63 · 2025: 79 · 2024: 64 · 2023: 83 · 2022: 78 · 2021: 78 · 2020: 94 · 2019: 80 · 2018: 78 · 2017: 109 · 2016: 90 · 2015: 99 · 2014: 88 · 2013: 97 · 2012: 94
- FWCI
- 57.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- Bristol-Myers Squibb
- Vanderbilt University
- Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
- National Institutes of Health (20565, 2r01ai020565-29, 5r01ca118582-05, AI-20565)
- U.S. Public Health Service (AI-AADCRC-U19-070364)
- National Cancer Institute (R01-CA-118582, P50CA095103, P50CA95103)
- National Institute of Allergy and Infectious Diseases (AI 20565, R01AI035796, R01AI-020565, AI/EHS-35796, R29AI035796, R37AI020565)
- National Institute of Dental and Craniofacial Research (R01DE017982)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Keywords
- cetuximab, anaphylaxis, drug hypersensitivity, IgE antibodies, galactose-alpha-1,3-galactose, Fab fragment, monoclonal antibodies, epidermal growth factor receptor, pre-existing antibodies, colorectal cancer, head and neck squamous cell carcinoma
- MeSH terms
- Cetuximab, Adult, Aged, Aged, 80 and over, Anaphylaxis, Antibodies, Monoclonal, Epitopes, Antineoplastic Agents, Cross Reactions, Disaccharides, Female, Humans, Immunoglobulin E, Male, Middle Aged, Protein Binding, Protein Conformation, Case-Control Studies, Antibodies, Monoclonal, Humanized, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.